Premier Health of America (CVE:PHA – Free Report) had its target price reduced by Acumen Capital from C$0.95 to C$0.65 in a research note published on Monday morning, MarketBeat.com reports. Acumen Capital currently has a speculative buy rating on the stock. Separately, Leede Jones Gab reaffirmed a buy rating on shares of Premier Health of […]